Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetic considerations in abuse liability evaluation.

M Farré1, J Camí

  • 1Institut Municipal d'Investigació Mèdica, Barcelona, Spain.

British Journal of Addiction
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jorge Manzanares: posthumous tribute to a great researcher, teacher, and friend.

Adicciones·2026
Same author

Effects of starter feeding strategies and hatching systems on performance, intestinal health, and bone mineralisation in broiler chickens.

Animal : an international journal of animal bioscience·2026
Same author

Faecal inflammatory biomarkers as non-invasive indicators of feed intake status in weaned piglets.

Animal : an international journal of animal bioscience·2025
Same author

Spontaneous adverse drug reactions reported in a thirteen-year pharmacovigilance program in a tertiary university hospital.

Frontiers in pharmacology·2024
Same author

Kinetics and toxicity of nanoplastics in ex vivo exposed human whole blood as a model to understand their impact on human health.

The Science of the total environment·2024
Same author

Fate of pharmaceuticals in the Ebro River Delta region: The combined evaluation of water, sediment, plastic litter, and biomonitoring.

The Science of the total environment·2023

Drug abuse liability is influenced by pharmacological activity and pharmacokinetic factors like absorption and metabolism. Understanding these pharmacokinetic parameters is crucial for evaluating drug abuse potential.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Drug Abuse Research

Background:

  • Drug behavioral effects depend on intrinsic activity, physicochemical properties, and pharmacokinetics.
  • Pharmacokinetic differences (absorption, distribution, metabolism, elimination) often explain varying abuse liability within drug classes.

Purpose of the Study:

  • To elucidate the role of pharmacokinetic parameters in determining drug abuse liability.
  • To highlight the importance of pharmacokinetic studies in human drug abuse evaluations.

Main Methods:

  • Review of factors influencing drug behavioral effects.
  • Analysis of pharmacokinetic parameters (absorption, distribution, metabolism, elimination) and their impact on drug abuse liability.
  • Discussion of genetic variations in drug metabolism (e.g., poor vs. extensive metabolizers).

Related Experiment Videos

Main Results:

  • Rapid absorption and high lipid solubility increase early brain concentrations, contributing to abuse liability.
  • Metabolism variations (dose-dependent kinetics, first-pass effect, genetic traits) and active metabolites influence drug effects.
  • Rapid elimination correlates with increased self-administration and earlier withdrawal symptoms.

Conclusions:

  • Pharmacokinetic parameters are critical for understanding and comparing the abuse liability of drugs.
  • Further pharmacokinetic research in humans is essential for accurate drug abuse liability assessments.
  • Plasma drug concentrations and pharmacokinetic data are key to interpreting inter-drug differences in abuse potential.